Monodonal antibodies were used in this study to immunoloa t e glycosaminoglycans throughout the human growth plate. Chondroitin-4-suUatefate, chondroitin-6-dateulfate, and keratan sulfate were observed in the extracellular matrix of all zones of the growth plate and persisted into the cartilage trabeculae of newly formed metaphyseal bone. Also present in the extracellular matrix was an oversulfated chondmitiddermatan sulfate glycosaminoglycan which appeared to be specific to the proliferative and hypertrophic zones of the growth plate.
Introduction
The ordered longitudinal growth of the skeleton throughout childhood is achieved through the proliferation, maturation, and hypertrophy of chondrocytes in the epiphyseal growth plate. New bone is formed on calcified cartilage trabeculae which remain as the terminal hypertrophic chondrocytes are removed by invading blood vessels from the metaphysis. This process of cartilage formation, growth, and removal is known as endochondral ossification and continues until skeletal maturity, at which time the epiphyseal and metaphyseal bones fuse and the growth plate ceases to exist as a distinct structure (10).
The growth plate itself consists of several morphologically distinct zones in which a graduation in cell shape and size and in matrix volume and composition is observed as the chondrocytes progress through their life cycle. Briefly, it consists of the resting zone which lies adjacent to the secondary bony epiphysis. The function to the cells. This epitope was not found to any significant extent in the other zones. The pericellular region around hypertrophic chondrocytes also contained a keratan sulfate epitope which was also observed in the resting zone but not in the p r o k t i w zone. These cell-associated glyamnhoglycans were not found in the cartilage trabeculae ofmetaphyseal bone, indicating their removal as the terminal hypertrophic chondroqtes and their lacunae are removed by invading blood vessels. These changes in matrix glycosaminoglycan content, both in the different zones and within zones, indicate constant subtle alterations in chondrocyte metabolic products as they proceed through their life qcle of proliferation, maturation, and hyperaophy.(/H;stochun Cpocftem KEY WORDS: Growth plate cartilage; Glycosaminoglycans; Proteoglycans; Monoclonal antibodies.
40:275-282, 1992)
of this zone is unknown, but it may act like other cartilages in being the primary zone of stress distribution and transmission. The proliferative zone lies next to the resting zone and appears to be responsible for cell proliferation and matrix synthesis. Together with the enlargement of hypertrophic cells, it is thereby responsible for longitudinal growth. Between this zone and the metaphyseal bone lies the hypertrophic zone, in which cell enlargement and calcification of the cartilage matrix are observed before blood vessel invasion and the deposition of new bone (1) .
In each of these zones the chondrocytes are surrounded by an extensive extracellular matrix which is synthesized and organized by the cells and which plays an important role in determining the functional integrity of the tissue. As with other cartilages, the major extracellular matrix molecules are collagens and large aggregating proteoglycans (11.20). The collagens consist of predominantly Type 11, with lesser amounts of Types M and XI. In addition, a unique collagen, Type X, is found exclusively in the hypertrophic zone of the growth plate (8,lS). The proteoglycans contain chondroitin-4-sulfate, chondroitin-6-sulfate, and keratan sulfate, and changes in proteoglycan monomer size and in the spacing of monomers on the hyaluronic acid chain have been reported in the different regions of the growth plate (2,ll). However, the relationship between these changes, specifically as they occur in the hyper-trophic region, and the process by which cell hypertrophy, matrix mineralization, and vascular invasion is initiated and perpetuated, are still unclear.
This study proposes to examine in more detail the constituent structural components of the proteoglycan molecule and their distribution throughout the growth plate, using tissue sections and immunolocation analysis with specific monoclonal antibodies that recognize glycosaminoglycan epitopes.
Materials and Methods
Horseradish peroxidase-conjugated sheep anti-mouse immunoglobulin was purchased from Silenus (Melbourne, Australia). Dimethylaminobenzidine substrate was purchased from Sigma Chemicals (St Louis, MO). Chondroitin ABC lyase (EC 4.2.2.4) was purchased from ICN Immunobiologicals (Costa Mesa, CA).
The costochondral junction, consisting of the costal cartilage, growth plate, and underlying subchondral bone of a 1.5-month-old male child was obtained from autopsy. The cause of death was Sudden Infant Death Syndrome, and the growth tissues were therefore considered normal. This specimen was chosen as being representative of the staining pattern observed in the growth plate cartilage of eight ribs, one distal ulna, one distal femur, and the proximal phalanx of an accessory toe, from separate individuals aged 7 days to 13 years.
The tissue was cleared of surrounding muscle and connective tissue and cut longitudinally into 2-mm sections, such that each section contained a linear progression of growth plate zones from the costal surface to the subchondral metaphyseal bone. Fixation and decalcification were carried out simultaneously in 10% (v/v) buffered formalin containing 5% (wlv) Naz-EDTA and 2% (w/v) cetyl pyridinium chloride. The tissue samples were then dehydrated, embedded in paraffin, and cut into 5-pm sections.
Before immunolocation analysis the tissue sections were de-waxed by sequential washes in xylene, absolute ethanol, 90% (v/v) ethanol, 70% (v/v) ethanol, and water. Immunostaining with specific monoclonal antibodies recognizing glycosaminoglycan epitopes was carried out as previously described (323. Horseradish peroxidase-conjugated sheep anti-mouse immunoglobulin second antibody and diaminobenzidine substrate were used to visualize primary antibody reactivity. Sections were counterstained with Mayers' hemotoxylin to give definition. Control sections minus first antibody incubations were included.
When necessary, tissue sections were digested with 0.05 U/ml chondroitinase ABC lyase in 0.1 M Tris-acetate buffer, pH 7.5, for 1 hr at 37'C before the addition of first antibody, to expose epitopes.
The epitope specificities of the antibodies used in this analysis are described in part in Eble 1 and more fully elsewhere (3) (4) (5) (6) (7) (17) (18) (19) , and the following dilutions were 
Results
The morphology of the human costochondral junction is shown in the toluidine blue section in Figure 1 . The cells of the costal cartilage here designated the resting zone are small, spherical, and for the most part exist singly or in pairs, separated by extracellular matrix. As the proliferative zone is reached the cells become flattened and are arranged in columns. Around columns of cells lacunae or pericellular regions are observed, and there appears to be less toluidine blue staining in these areas. The hypertrophic zone is characterized by the progressive increase in cell size as the metaphyseal bone is approached, while a concomitant decrease in matrix volume is observed. In the newly formed metaphyseal bone, cartilage trabeculae can be clearly seen. The costochondral junction, particularly in young individuals, therefore presents as a typical growth plate exhibiting a structure and organization similar to that of the long bones before the appearance of the secondary center of ossification. The distribution of chondroitin-4-sulfate and chondroitin-6sulfate, as determined by immunolocation with antibodies 2-B-6 and 3-B-3 after chondroitinase ABC digestion, can be seen in Figures  2A and 2B . Both glycosaminoglycans are found throughout the extracellular matrix of all zones of the growth plate. Except for decreased staining associated with chondroitin-4-sulfate in the pericellular region of the proliferative zone, both epitopes are also observed in close association with the cells. The perichondrium is preferentially recognized by 2-B-6, indicating that more chondroitin-4-sulfate is present in this area. Both chondroitin4 and -6-sulfate persist in the cartilage trabeculae which extend into the metaphyseal bone. As these glycosaminoglycans are found on the large proteoglycans typical of cartilage, this pattern of staining supports previous findings (13) and indicates the widespread occurrence of this proteoglycan species throughout the growth plate.
When antibody 3-B-3 was used without prior digestion by chondroitinase ABC, a vastly different immunolocation pattern was observed ( Figure 3 ). Staining was associated only with cells i n the hypertrophic zone and lower proliferative zone, indicating the presence of chondroitin sulfate chains terminating in a uronic acid moiety adjacent to a galactosamine sulfated in the 6 position. Not all of the cells in these zones appeared to exhibit this epitope, and anti- body reactivity was not observed in the extracellular matrix. Cells in the upper proliferative zone and perichondrium did not stain.
Occasionally, a cell in the resting zone adjacent to the perichondrium was positive for this epitope; however, overall the resting zone was negative for this epitope. In addition, no staining was observed in the cartilage trabeculae of metaphyseal bone, emphasizing the cell-associated nature of this epitope. Several monoclonal antibodies that recognize epitopes on native chondroitiddermatan sulfate chains were also utilized (results not shown). Two of the antibodies tested, 4-D-3 and 6-C-3, exhibited a similar pattern of staining to that already demonstrated by 2-B-6 and 3-B-3 after chondroitinase ABC digestion, although of a lower intensity. Antibodies 3 4 -5 and 4-C-3 did not recognize epitopes in growth plate cartilage. A differential reactivity was observed with antibodies 4-C-3 and 4-D-3 in the perichondrium. 4-C-3 was strongly reactive with an epitope in this tissue which was not present in the adjacent cartilage, whereas 4-D-3 presented the opposite picture. Although the epitopes for these antibodies have not 
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trabeculae of the metaphyseal bone. As can be seen most clearly in the lower proliferative zone, this epitope is found predominantly in the extracellular matrix and is excluded from the pericellular matrix or lacunae around the cells. The resting zone was largely devoid of 7-D-4 reactivity, except for those areas immediately adjacent to the perichondrium, which also stained strongly with this antibody.
The distribution of keratan sulfate in the growth plate is shown in Figures SA and 5B . Only when the tissue sections were digested with chondroitinase ABC to remove chondroitinldermatan sulfate chains was strong reactivity with anti-keratan sulfate antibodies observed. The staining pattern followed that of 2-B-6 and 3-B-3 after chondroitinase ABC digestion, and is indicative of the keratan sulfate portion of the large proteoglycan molecule. Strong staining was evident throughout the extracellular matrix of each of the zones of the growth plate, the perichondrium, and the cartilage trabeculae of metaphyseal bone. In the proliferative zone, decreased staining was observed in the lacunae surrounding chondrocytes. As antikeratan sulfate antibodies d o not usually require prior digestion with chondroitinase ABC to expose epitopes, the necessity for digestion in this case probably reflects a steric hindrance to antibody Pe *.
binding by nearby chondroitin sulfate chains as the proteoglycans collapse on tissue processing and section preparation. This may also explain previous reports of decreased or negative amounts of keratan sulfate glycosaminoglycan in epiphyseal cartilage in the absence of chondroitin ABC lyase digestion (17) .
In the absence of digestion with chondroitinase ABC, 5-D-4 antibody reactivity was observed closely associated with cells in the hypertrophic and resting zones. The extracellular matrix of these areas demonstrated little or reduced staining, and neither the chondrocytes nor the extracellular matrix of the proliferative zone exhibited a positive reaction to this antibody.
This unusual pattern of anti-keratan sulfate staining in the presence and absence of prior chondroitinase ABC lyase digestion was confirmed by immunolocation analysis with additional anti-keratan sulfate antibodies, including l-B-4,4-D-l, 3-D-2, and 8-C-2 (results not shown). 
Discussion
This study has shown that the glycosaminoglycan content varies throughout the different zones of the human growth plate and between the pericellular and extracellular regions within a given zone.
The typical cartilage proteoglycan glycosaminoglycan constituents of chondroitin-4-suIfate, chondroitin-6-sulfate, and keratan sulfate were found in the pericellular and extracellular matrix of each of the zones after chondroitinase ABC digestion to expose epitopes. This confirms the previous observation of the presence , * -. , been fully characterized, they provide a useful method of distinguishing between the perichondrium and growth plate cartilage matrix glycosaminoglycans. However, one monoclonal antibody, 7-D-4, which recognizes native chondroitinldermatan sulfate chains, demonstrated an interesting distribution in growth plate cartilage (Figure 4) . A gradient of staining intensity was observed, with 7-D-4 reactivity appearing in the mid proliferative zone and persisting through the remainder of this zone, the hypertrophic zone, and the cartilage of hyaluronic acid binding region and link protein (and therefore of aggregating proteoglycans) in the growth plate and cartilage trabeculae of metaphyseal bone (13) . We did not observe the increased chondroitin-4-sulfate presence in the pericellular matrix reported by other workers (9) .
Of particular interest in this study was the appearance of a zonespecific glycosaminoglycan epitope recognized by antibody 7-D-4, which increased in concentration as the chondrocytes proceeded through their proliferative and hypertrophic stages. This antibody production of oversulfated glycosaminoglycans on proteoglycans synthesized by chondrocytes in the proliferative and hypertrophic regions of the growth plate is unknown. Oversulfation may play a role in maintaining the biomechanical properties of this tissue, or it may participate in the localization and concentration of biologically active molecules that regulate chondrocyte maturation and hypertrophy (14) .
The pericellular and extracellular regions of the different zones of the growth plate also demonstrated differences in antibody reactivity, which were apparent only when the chondroitinase digestion step was omitted. Pericellular keratan sulfate glycosaminoglycan was observed in the lacunae surrounding hypertrophic chondrocytes, where it appeared to be intimately associated with the cells. This epitope was not observed around chondrocytes in the proliferative zone. It is possible that this pericellular keratan sulfate may be a component of a different species of proteoglycan from that in the extracellular matrix. A family of small keratan sulfate-containing proteoglycans (fibromodulin) have recently been characterized in cartilage (12). The antibody 5-D-4 will not distinguish between the large and small keratan sulfate-containing proteoglycans. A further heterogeneity in the pericellular region was demonstrated by the presence of a glycosaminoglycan containing a 6-sulfated nonreducing terminal structure around hypertrophic cells. This epitope has previously been located only in young or osteoarthritic articular cartilage (7), where this unusual structure most likely represents a novel biosynthetic end-product in these tissues. Less likely is the possibility that it may represent a degradation product of normal chondroitin-6-sulfate glycosaminoglycan chains (endogeoous hyaluronidase will produce this epitope) in tissues with a high level of matrix turnover. Therefore, it appears that the expression of specific cell-associated glycosaminoglycans, whose function may involve cell-matrix communication, is modulated as chondrocytes undergo hypertrophy. This modulation may have functional significance in preparing the matrix for mineralization and/or vascular invasion.
Growth plate cartilage is a highly ordered tissue in which a strict sequence of events is followed as chondrocytes proliferate, mature, and hypertrophy, and is associated with changes in cell and matrix composition and configuration. Growth plate chondrocytes may direct this process of endochondral ossification by the expression of altered matrix products that have the capacity to participate either directly in the developmental process or indirectly through an interaction with biologically active molecules at specific stages of the chondrocyte life cycle.
